Catalyst Pharmaceuticals Stock Price

0.02 (0.29%)
Upgrade to Real-Time
Afterhours (Closed)
Volume 1,248,458
Bid Price 6.00
Ask Price 7.19
News -
Day High 7.10


52 Week Range


Day Low 6.865
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Small Cap Pro
Monthly Subscription
for only
DDE w/Realtime (Monthly)
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Catalyst Pharmaceuticals Inc CPRX NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.02 0.29% 7.03 00:00:04
Open Price Low Price High Price Close Price Prev Close
6.99 6.865 7.10 7.06 7.01
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
13,168 1,248,458 $ 7.00 $ 8,738,437 - 4.81 - 8.645
Last Trade Time Type Quantity Stock Price Currency
19:48:18 1 $ 6.81 USD


Draw Mode:

Catalyst Pharmaceuticals Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 722.54M 102.78M 95.03M $ 140.83M $ 41.25M 0.37 16.40
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - -20.00k 9.50%

more financials information »

Catalyst Pharmaceuticals News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical CPRX Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week6.747.2256.4256.821,528,6870.294.3%
1 Month7.087.476.156.701,186,516-0.05-0.71%
3 Months8.258.646.157.131,159,805-1.22-14.79%
6 Months6.838.6455.247.201,154,6200.202.93%
1 Year5.718.6454.816.711,025,1001.3223.12%
3 Years3.888.6452.554.881,585,1683.1581.19%
5 Years2.768.6451.854.361,453,0214.27154.71%

Catalyst Pharmaceuticals Description

Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing innovative therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers Firdapse, a proprietary form of amifampridine phosphate for the treatment of patients with Lambert-Eaton myasthenic syndrome.

Your Recent History
Catalyst P..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.